FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
4 sources reported this story →
The risk appears small and data is mixed, but FDA wants patients to be aware.
This story comes from Ars Technica's feed; the full article and all rights belong to the source.
Comments (0)
No comments yet. Be the first to comment.
Sign in to write a comment.